Home
Public services
Dashboard
Curated content
Startups & Scaleups
New startups
Job board
Corporates
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More organizations
Matching tool
Investment heatmap
Themes
Reports
Companies
Currus Biologics
Save
Currus Biologics
Utilizing its proprietary BEAT technology to develop CAR-T cell therapies for the treatment of solid tumor cancers, traditionally difficult to treat with current CAR-T cell therapies.
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Recent News about Currus Biologics
Edit